Key Client Fiduciary Advisors »

Cytosorbents shares owned by Key Client Fiduciary Advisors

Quarter-by-quarter ownership of Cytosorbents (CTSO) shares owned by Key Client Fiduciary Advisors from 13F filings

Historical chart of Key Client Fiduciary Advisors investment in Cytosorbents

Tip: Access up to 7 years of quarterly data

All positions including Cytosorbents held by Key Client Fiduciary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytosorbents by Key Client Fiduciary Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $33k 35k 0.95
2023-12-31 $13k 12k 1.11
2023-09-30 $24k 13k 1.88
2023-06-30 $43k 12k 3.59
2023-03-31 $40k 12k 3.37
2022-12-31 $19k 12k 1.55
2022-09-30 $16k 12k 1.33
2022-06-30 $26k 12k 2.17

More positions owned by Key Client Fiduciary Advisors

Microsoft Corporation (MSFT)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Apple (AAPL)
First Tr Exchange-traded Indxx Aerospace (MISL)
First Tr Morningstar Divid L SHS (FDL)
First Tr Value Line Divid In SHS (FVD)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Prudential Financial (PRU)
Annaly Capital Management In Com New (NLY)
Abbvie (ABBV)

View all positions for Key Client Fiduciary Advisors

Top funds holding Cytosorbents

Skylands Capital
Avenir Corporation
Vanguard Group
Neuberger Berman Group
Sargent Investment Group
CM Management
Advisor Group Holdings
Bank of America Corporation
Raymond James Financial Services Advisors
Dimensional Fund Advisors
Raymond James & Associates
Millennium Management
Stifel Financial
Key Client Fiduciary Advisors
Chicago Partners Investment

View all funds holding Cytosorbents